P&K Skin Research Center Co., Ltd. (KOSDAQ:347740)
South Korea
· Delayed Price · Currency is KRW 2,415.00
-55.00 (-2.23%)
At close: Dec 5, 2025
P&K Skin Research Center Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Operating Revenue | 22,131 | 17,847 | 14,843 | 17,957 |
| Other Revenue | -0 | -0 | - | - |
| Revenue | 22,131 | 17,847 | 14,843 | 17,957 |
| Revenue Growth (YoY) | 25.24% | 20.24% | -17.34% | - |
| Cost of Revenue | 11,875 | 9,409 | 7,668 | 6,865 |
| Gross Profit | 10,256 | 8,438 | 7,175 | 11,092 |
| Selling, General & Admin | 4,282 | 3,828 | 3,918 | 3,428 |
| Research & Development | 1,586 | 1,519 | 1,357 | 1,670 |
| Other Operating Expenses | 24.73 | 23.15 | 29.3 | 19.82 |
| Operating Expenses | 6,329 | 5,856 | 5,796 | 5,452 |
| Operating Income | 3,927 | 2,582 | 1,379 | 5,640 |
| Interest Expense | -45.21 | -26.49 | -32.77 | -25.77 |
| Interest & Investment Income | 3,222 | 3,753 | 3,808 | 2,215 |
| Currency Exchange Gain (Loss) | -0.49 | 0.86 | -0.29 | 0.03 |
| Other Non Operating Income (Expenses) | -190.16 | -224.19 | 63.36 | 546.89 |
| EBT Excluding Unusual Items | 6,913 | 6,085 | 5,217 | 8,377 |
| Gain (Loss) on Sale of Investments | 936.67 | 712.69 | 140.01 | -185.18 |
| Gain (Loss) on Sale of Assets | -0.99 | -0.31 | -0 | -0.97 |
| Pretax Income | 7,849 | 6,797 | 5,357 | 8,190 |
| Income Tax Expense | 1,278 | 1,097 | 656.54 | 1,060 |
| Earnings From Continuing Operations | 6,571 | 5,701 | 4,700 | 7,130 |
| Minority Interest in Earnings | 75.91 | 115.58 | 112.75 | - |
| Net Income | 6,647 | 5,816 | 4,813 | 7,130 |
| Net Income to Common | 6,647 | 5,816 | 4,813 | 7,130 |
| Net Income Growth | -1.72% | 20.84% | -32.50% | - |
| Shares Outstanding (Basic) | 29 | 29 | 30 | 30 |
| Shares Outstanding (Diluted) | 29 | 29 | 30 | 30 |
| Shares Change (YoY) | -1.43% | -3.19% | 0.58% | - |
| EPS (Basic) | 230.14 | 200.32 | 160.48 | 239.12 |
| EPS (Diluted) | 230.14 | 200.32 | 160.48 | 239.12 |
| EPS Growth | -0.30% | 24.83% | -32.89% | - |
| Free Cash Flow | 5,447 | 8,410 | 4,023 | 6,277 |
| Free Cash Flow Per Share | 188.61 | 289.65 | 134.13 | 210.50 |
| Dividend Per Share | 40.000 | 40.000 | 30.000 | 35.000 |
| Dividend Growth | 33.33% | 33.33% | -14.29% | - |
| Gross Margin | 46.34% | 47.28% | 48.34% | 61.77% |
| Operating Margin | 17.75% | 14.47% | 9.29% | 31.41% |
| Profit Margin | 30.04% | 32.59% | 32.43% | 39.71% |
| Free Cash Flow Margin | 24.62% | 47.12% | 27.10% | 34.96% |
| EBITDA | 5,923 | 4,431 | 3,114 | 7,108 |
| EBITDA Margin | 26.76% | 24.83% | 20.98% | 39.59% |
| D&A For EBITDA | 1,996 | 1,848 | 1,735 | 1,468 |
| EBIT | 3,927 | 2,582 | 1,379 | 5,640 |
| EBIT Margin | 17.75% | 14.47% | 9.29% | 31.41% |
| Effective Tax Rate | 16.29% | 16.13% | 12.26% | 12.95% |
| Advertising Expenses | - | 92.33 | 123.34 | 312.82 |
Source: S&P Capital IQ. Standard template. Financial Sources.